InvestorsHub Logo
icon url

adreamer

10/25/12 11:23 PM

#23407 RE: JJM760 #23406

Whether you use it continuously ... or stop use and call it a cure...Ponatinib will prove superior....These efforts by Novartis are expected....I would much prefer to have the best in class molecule...and I believe we have it.........:0)